Evidence map›Paper›PMID 41894050›Full record

ArticleMikrochimica acta2026

Establishment of a microinterface between zinc-porphyrin-organic framework and ZnO nanoparticles for electrochemiluminescence aptasensing microRNA-122 in living cancer cells.

Shuai Zhang, Yi Li, Chuanpan Guo, Zhihong Zhang, Yuqi Guo

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shuai ZhangHenan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China. zhangs@zzuli.edu.cn.
Yi LiHenan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China.
Chuanpan GuoCollege of Material and Chemical Engineering, Institute of New Energy Science and Technology, School of Future Hydrogen Energy Technology, Zhengzhou University of Light Industry, Zhengzhou, 450001, PR China.
Zhihong ZhangCollege of Material and Chemical Engineering, Institute of New Energy Science and Technology, School of Future Hydrogen Energy Technology, Zhengzhou University of Light Industry, Zhengzhou, 450001, PR China.
Yuqi GuoHenan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China. yuqiguo@zzu.edu.cn.

Funding

Joint Fund of Provincial Science and Technology Research, Development Plan of Henan Province 225200810015Outstanding foreign scientist studio project of Henan province GZS2023013Program for Innovative Research Team (in Science and Technology) in University of Henan Province 25IRTSTHN003
6 · The paper itself

Abstract

The precise detection of microRNAs (miRNAs) in tumor tissue is vital for the early diagnosis of cancer. In this work, we propose an electrochemiluminescence (ECL) aptasensing strategy for the sensitive detection of miRNA-122 in living cancer cells. To tremendously amplify the ECL response, a zinc-porphyrin-organic framework embraced with ZnO nanoparticles (NPs), which was synthesized through solvothermal synthesis using 5,10,15,20-tetra(4-pyridyl)porphyrin (TPyP) as linking ligand and zinc nitrate as precursor (represented by Zn-TPyP@ZnO), simultaneously served as bioplatform and ECL emitter in the presence of the coreactant K2S2O8. The generation of a microinterface between Zn-TPyP and ZnO NPs endowed fast electron transfer, improved catalytic performance, and superior biocompatibility. These advantages of the Zn-TPyP@ZnO heterojunction confers the system with strong reduction capability toward S2O82− to generate SO4•− and toward O2 to produce O2•− or •OH, as well as excellent anchoring capability for the miRNA-122-targeted aptamer. Therefore, the developed Zn-TPyP@ZnO-based ECL aptasensor demonstrated a wide linear detection range from 10 fM to 10 nM with an ultralow detection limit of 0.77 fM, accompanied with high selectivity, good stability, and excellent reproducibility. The constructed ECL aptasensor also showed promising application for the detection of miRNA-122 in living cancer cells. Thereby, the present work not only provides a new ECL aptasensing strategy for the sensitive detection of miRNA in living cancer cells but also puts forward the advancement of the early diagnosis of tumors.

Indexed as

Aptamers, NucleotideBiosensing TechniquesMetalloporphyrinsMetal NanoparticlesMetal-Organic FrameworksMicroRNAsNanoparticlesZinc OxideElectrochemical TechniquesHumansLimit of DetectionLuminescent MeasurementsAptamers, NucleotideMetalloporphyrinsMetal-Organic FrameworksMicroRNAsMIRN122 microRNA, humanzinc hematoporphyrinZinc OxideDetection of miRNA-122Early tumor diagnosisElectrochemiluminescence aptasensorZinc-porphyrin-organic frameworkZnO nanoparticles

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.